Social network-based ethical analysis of COVID-19 vaccine supply policy in three Central Asian countries

被引:0
作者
Timur Aripov
Daniel Wikler
Damin Asadov
Zhangir Tulekov
Totugul Murzabekova
Kerim M. Munir
机构
[1] Tashkent Institute of Postgraduate Medical Education,Department of Public Health and Healthcare Management
[2] Harvard School of Public Health,Department of Global Health and Population
[3] Al-Farabi Kazakh National University,Harvard Medical School
[4] Kyrgyz-Netherlands Community of Volunteers Tuberculosis Foundation,undefined
[5] Boston Children’s Hospital,undefined
[6] Developmental Medicine Center,undefined
来源
BMC Medical Ethics | / 23卷
关键词
COVID-19; Vaccine; Bioethics; Low- and middle-income countries; Central Asia;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 52 条
[1]  
So AD(2020)Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis BMJ 371 1023-1034
[2]  
Woo J(2021)Covax must go beyond proportional allocation of covid vaccines to ensure fair and equitable access BMJ 372 129-139
[3]  
Herzog L(2021)A WHO’s allocation framework for COVAX: is it fair? J Med Ethics 397 124-134
[4]  
Norheim O(2021)Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment Lancet 15 1614-1616
[5]  
Emanuel E(2012)The ethics of 'public understanding of ethics'–why and how bioethics expertise should include public and patients' voices Med Health Care Philos 78 671-681
[6]  
Sharma S(2020)Safety and efficacy of the BNT162b2 mRNA Covid-19 Vaccine N Engl J Med 396 493-503
[7]  
Kawa N(2017)Opinion summarization methods: comparing and extending extractive and abstractive approaches Expert Syst Appl 373 99-111
[8]  
Gomber OJ(2020)Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination Lancet 372 78-85
[9]  
Wouters KC(2021)How long does covid-19 immunity last? BMJ 397 1973-1987
[10]  
Shadlen M(2021)Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study BMJ 59 2905-2912